These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 14768038)

  • 21. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
    Chung Y; Lee SH; Kim DH; Kang CY
    J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ex vivo microenviroments in MLTC of poorly immunogenic tumor cells facilitate polarization of CD4+CD25+ regulatory T cells.
    Wang Y; Zhou L; Wang HY; Xiao JX; Si LS; Wang YL
    Cell Mol Immunol; 2006 Apr; 3(2):123-9. PubMed ID: 16696899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
    Ye Z; Wang Y; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of IL-12 and a novel negative feedback system mediated by CD25+CD4+ T cells.
    Sato K; Tateishi S; Kubo K; Mimura T; Yamamoto K; Kanda H
    Biochem Biophys Res Commun; 2005 Apr; 330(1):226-32. PubMed ID: 15781254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.
    Wei WZ; Jacob JB; Zielinski JF; Flynn JC; Shim KD; Alsharabi G; Giraldo AA; Kong YC
    Cancer Res; 2005 Sep; 65(18):8471-8. PubMed ID: 16166327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
    Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
    J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic activity of lymphocytes infiltrating progressive and regressive tumor variants from a rat colonic cancer.
    Pelletier H; Olsson NO; Lizard G; Martin F
    Immunobiology; 1991 Mar; 182(2):188-96. PubMed ID: 1885206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bryostatin/ionomycin-activated T cells mediate regression of established tumors.
    Chin CS; Graham LJ; Hamad GG; George KR; Bear HD
    J Surg Res; 2001 Jun; 98(2):108-15. PubMed ID: 11397126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta/interleukin-2-induced regulatory CD4+ T cells prolong cardiac allograft survival in rats.
    Watanabe M; Mencel RL; Cramer DV; Starnes VA; Barr ML
    J Heart Lung Transplant; 2005 Dec; 24(12):2153-9. PubMed ID: 16364865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
    Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.
    Erdman SE; Rao VP; Poutahidis T; Ihrig MM; Ge Z; Feng Y; Tomczak M; Rogers AB; Horwitz BH; Fox JG
    Cancer Res; 2003 Sep; 63(18):6042-50. PubMed ID: 14522933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
    Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic ones.
    Zhang X; Kedl RM; Xiang J
    Biochem Biophys Res Commun; 2009 Feb; 379(4):954-8. PubMed ID: 19135981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.
    Kurooka M; Kaneda Y
    Cancer Res; 2007 Jan; 67(1):227-36. PubMed ID: 17210703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.